SCHEMBL6846552

SCHEMBL6846552

CN(Cc1ccccc1)C(=O)OCc1cncn1Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 8/20 0.54
▸ CYP11B2 P19099 8/20 0.54
▸ CHRNB2 P17787 1/20 0.45
▸ CHRNB4 P30926 1/20 0.45
▸ CHRNA3 P32297 1/20 0.45
▸ CHRNA4 P43681 1/20 0.45
▸ FNTA P49354 1/20 0.44
▸ FNTB P49356 1/20 0.44
▸ PGGT1B P53609 1/20 0.44
▸ IDO1 P14902 2/20 0.41
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7259729 0.82 CYP11B1 (0.61) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL13687204 0.76 CHRNB2 (0.61) CHRNB2CHRNB4CHRNA3CHRNA4NPC1
SCHEMBL16892166 0.75 CYP11B1 (0.60) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL6776094 0.73 CYP11B1 (0.62) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL2789150 0.72 CYP11B1 (0.61) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL14476557 0.72 CYP11B1 (0.57) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL2789863 0.72 CYP11B1 (0.76) CYP11B1CYP11B2FNTAFNTBPGGT1B
SCHEMBL698418 0.72 CHRNB2 (0.60) CHRNB2CHRNB4CHRNA3CHRNA4NPC1
SCHEMBL20683501 0.71 CHRNB2 (0.53) CHRNB2CHRNB4CHRNA3CHRNA4NPC1
SCHEMBL16886091 0.71 CYP11B1 (0.54) CYP11B1CYP11B2FNTAFNTBPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699898-B2 METHOD OF TREATING CORONARY ARTERY DISEASE OR OTHER CETP-MEDIATED DISORDERS IN A SUBJECT BY ADMINISTERING A THERAPEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND OF ONE OF CLAIMS PHARMACIA CORPORATION GLOBAL PATENT DEPARTMENT 2004-03-02 — — US disclosed
Send feedback